MedPath

常州制药厂有限公司

Ownership
-
Established
2001-12-14
Employees
-
Market Cap
-
Website
www.czzyc.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

128

NMPA:128

Drug Approvals

Ursodeoxycholic Acid Capsules

Product Name
熊去氧胆酸胶囊
Approval Number
国药准字H20253177
Approval Date
Jan 14, 2025
NMPA

Apremilast Tablets

Product Name
阿普米司特片
Approval Number
国药准字H20249592
Approval Date
Dec 1, 2024
NMPA

Apremilast Tablets

Product Name
阿普米司特片
Approval Number
国药准字H20249593
Approval Date
Dec 1, 2024
NMPA

Apremilast Tablets

Product Name
阿普米司特片
Approval Number
国药准字H20249591
Approval Date
Dec 1, 2024
NMPA

Celecoxib Capsules

Product Name
塞来昔布胶囊
Approval Number
国药准字H20244510
Approval Date
Jul 30, 2024
NMPA

Lurasidone Hydrochloride Tablets

Product Name
盐酸鲁拉西酮片
Approval Number
国药准字H20244450
Approval Date
Jul 16, 2024
NMPA

Eltrombopag Olamine Tablets

Product Name
艾曲泊帕乙醇胺片
Approval Number
国药准字H20244420
Approval Date
Jul 9, 2024
NMPA

Sitagliptin Phosphate Tablets

Product Name
磷酸西格列汀片
Approval Number
国药准字H20244046
Approval Date
Jun 18, 2024
NMPA

Sitagliptin Phosphate Tablets

Product Name
磷酸西格列汀片
Approval Number
国药准字H20244048
Approval Date
Jun 18, 2024
NMPA

Sitagliptin Phosphate Tablets

Product Name
磷酸西格列汀片
Approval Number
国药准字H20244047
Approval Date
Jun 18, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.